BLLNBilliontoone Inc. - Ordinary Shares - Class A

Key PointsAccording to a Form 4 filing, a BillionToOne executive sold 801 shares of Class A Common Stock at $124.91 per share for a total transaction value of $100,053 on July 1, 2026...

In recent trading, shares of Billiontoone Inc (Symbol: BLLN) have crossed above the average analyst 12-month target price of $118.43, changing hands for $120.60/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v...

Here is how BillionToOne (BLLN) and Concentra Group (CON) have performed compared to their sector so far this year.

BillionToOne's Northstar Response Is a Stronger Predictor of Immunotherapy Outcomes Than Standard-of-Care Imaging for Cancer Patients in Peer-Reviewed Study BillionToOne's Northstar Response Is a Stronger Predictor of Immunotherapy Outcomes Than Standard-of-Care Imaging for Cancer Patients in...

Here is how Biodesix, Inc. (BDSX) and BillionToOne (BLLN) have performed compared to their sector so far this year.

Here is how BillionToOne (BLLN) and Eledon Pharmaceuticals, Inc. (ELDN) have performed compared to their sector so far this year.

The average of price targets set by Wall Street analysts indicates a potential upside of 37% in BillionToOne (BLLN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Jim Cramer on BillionToOne: I Say Buy It...

"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed...